{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:31:28Z","timestamp":1761975088715,"version":"3.44.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.jaci.2009.05.019","type":"journal-article","created":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T05:19:47Z","timestamp":1247203187000},"page":"349-356.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Toll-like receptor 7 and 9 defects in common variable immunodeficiency"],"prefix":"10.1016","volume":"124","author":[{"given":"Joyce E.","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adina K.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Radigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas U.","family":"Marron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Sanchez-Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Cunningham-Rundles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2009.05.019_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/ni902","article-title":"Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency","volume":"4","author":"Grimbacher","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.all.0000191888.97397.b3","article-title":"Tackling the heterogeneity of CVID","volume":"5","author":"Goldacker","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib3","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa051568","article-title":"An antibody-deficiency syndrome due to mutations in the CD19 gene","volume":"354","author":"van Zelm","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2009.05.019_bib4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2009.05.019_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2009.05.019_bib6","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes","volume":"120","author":"Zhang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2005.03.019","article-title":"Immune competence and switched memory B cells in common variable immunodeficiency","volume":"116","author":"Ko","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib8","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","article-title":"Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease","volume":"99","author":"Warnatz","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2009.05.019_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","article-title":"The EUROclass trial: defining subgroups in common variable immunodeficiency","volume":"111","author":"Wehr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2009.05.019_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","article-title":"Memory B cells in common variable immunodeficiency: clinical associations and sex differences","volume":"128","author":"Sanchez-Ramon","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib11","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1182\/blood-2002-11-3569","article-title":"A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells","volume":"101","author":"Bernasconi","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2009.05.019_bib12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1182\/blood-2002-11-3355","article-title":"The Toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells","volume":"102","author":"Bourke","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2009.05.019_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nri2038","article-title":"Cooperation of Toll-like receptor signals in innate immune defence","volume":"7","author":"Trinchieri","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2009.05.019_bib15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2009.05.019_bib16","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/eji.200323444","article-title":"CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides","volume":"33","author":"Gantner","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib17","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/eji.200323813","article-title":"Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells","volume":"33","author":"Hartmann","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib18","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.4049\/jimmunol.173.7.4479","article-title":"CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10","volume":"173","author":"He","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib19","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2003-08-2972","article-title":"Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help","volume":"103","author":"Poeck","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2009.05.019_bib20","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/eji.200535744","article-title":"Toll-like receptor stimulation as a third signal required for activation of human naive B cells","volume":"36","author":"Ruprecht","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib21","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.4049\/jimmunol.178.4.2415","article-title":"TLR9 signaling in B cells determines class switch recombination to IgG2a","volume":"178","author":"Jegerlehner","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib22","doi-asserted-by":"crossref","first-page":"8267","DOI":"10.4049\/jimmunol.181.12.8267","article-title":"TLR9-activating DNA up-regulates ZAP70 via sustained PKB induction in IgM+ B cells","volume":"181","author":"Bekeredjian-Ding","year":"2008","journal-title":"J Immunol"},{"issue":"suppl 2","key":"10.1016\/j.jaci.2009.05.019_bib23","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0264-410X(03)00198-1","article-title":"Antigen dependent and independent mechanisms that sustain serum antibody levels","volume":"21","author":"Traggiai","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jaci.2009.05.019_bib24","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.20050630","article-title":"RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement","volume":"202","author":"Lau","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2009.05.019_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2172-9-39","article-title":"Comparison of human B cell activation by TLR7 and TLR9 agonists","volume":"9","author":"Hanten","year":"2008","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaci.2008.09.018","article-title":"Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production","volume":"123","author":"Glaum","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib27","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1002\/eji.200324238","article-title":"The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily","volume":"33","author":"Heil","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib28","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaci.2009.05.019_bib29","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.176.3.1978","article-title":"TLR9 activation is defective in common variable immune deficiency","volume":"176","author":"Cunningham-Rundles","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","article-title":"Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee","volume":"120","author":"Geha","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2567.2008.02844.x","article-title":"Identification of two subpopulations of purified human blood B cells, CD27(-) CD23(+) and CD27(high) CD80(+), that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6","volume":"125","author":"Cognasse","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.jaci.2009.05.019_bib32","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.4049\/jimmunol.174.7.4043","article-title":"Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN","volume":"174","author":"Bekeredjian-Ding","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1046\/j.1440-1711.1999.00874.x","article-title":"Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester","volume":"77","author":"Hasbold","year":"1999","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jaci.2009.05.019_bib34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/ni829","article-title":"DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL","volume":"3","author":"Litinskiy","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CVI.13.1.68-76.2006","article-title":"Development of a clinical assay to evaluate Toll-like receptor function","volume":"13","author":"Deering","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib36","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0006-291X(02)00380-7","article-title":"Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling","volume":"293","author":"Matsumoto","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jaci.2009.05.019_bib37","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2009.05.019_bib38","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","article-title":"Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides","volume":"168","author":"Hornung","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0008-8749(02)00517-8","article-title":"Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod","volume":"218","author":"Gibson","year":"2002","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cytogfr.2007.10.006","article-title":"Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history","volume":"19","author":"Fitzgerald-Bocarsly","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaci.2009.05.019_bib41","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.4049\/jimmunol.178.12.7779","article-title":"TLR agonists selectively promote terminal plasma cell differentiation of B cell subsets specialized in thymus-independent responses","volume":"178","author":"Genestier","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4049\/jimmunol.180.2.800","article-title":"CpG drives human transitional B cells to terminal differentiation and production of natural antibodies","volume":"180","author":"Capolunghi","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib43","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.181.3.1746","article-title":"The agonists of TLR4 and 9 are sufficient to activate memory B cells to differentiate into plasma cells in vitro but not in vivo","volume":"181","author":"Richard","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib44","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nature04267","article-title":"Control of B-cell responses by Toll-like receptors","volume":"438","author":"Pasare","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2009.05.019_bib45","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1084\/jem.20071250","article-title":"B cell intrinsic TLR signals amplify but are not required for humoral immunity","volume":"204","author":"Meyer-Bahlburg","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2009.05.019_bib46","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ni712","article-title":"Toll-like receptors control activation of adaptive immune responses","volume":"2","author":"Schnare","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib47","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.jpeds.2003.11.025","article-title":"Interleukin receptor-associated kinase (IRAK-4) deficiency associated with bacterial infections and failure to sustain antibody responses","volume":"144","author":"Day","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2009.05.019_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.0105-2896.2005.00221.x","article-title":"Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation","volume":"203","author":"Orange","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2009.05.019_bib49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1126\/science.1128346","article-title":"Herpes simplex virus encephalitis in human UNC-93B deficiency","volume":"314","author":"Casrouge","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jaci.2009.05.019_bib50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1083\/jcb.200612056","article-title":"The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling","volume":"177","author":"Brinkmann","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jaci.2009.05.019_bib51","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1126\/science.1139522","article-title":"TLR3 deficiency in patients with herpes simplex encephalitis","volume":"317","author":"Zhang","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jaci.2009.05.019_bib52","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaci.2007.11.014","article-title":"IKBKG (nuclear factor-kappaB essential modulator) mutation can be associated with opportunistic infection without impairing Toll-like receptor function","volume":"121","author":"Salt","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib53","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon-like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2009.05.019_bib54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/intimm\/14.4.411","article-title":"IFN-alpha\/beta enhances BCR-dependent B cell responses","volume":"14","author":"Braun","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib55","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0198-8859(02)00751-6","article-title":"Natural type I interferon-producing cells as a link between innate and adaptive immunity","volume":"63","author":"Kadowaki","year":"2002","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2009.05.019_bib56","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.4049\/jimmunol.178.4.2182","article-title":"TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses","volume":"178","author":"Heer","year":"2007","journal-title":"J Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909008100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674909008100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:17:59Z","timestamp":1758788279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674909008100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0091674909008100"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2009.05.019","relation":{},"ISSN":["0091-6749"],"issn-type":[{"type":"print","value":"0091-6749"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-like receptor 7 and 9 defects in common variable immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2009.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}